Tower Research Capital (TRC)’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $848K | Buy |
|
|||||
|
2025
Q1 | $208K | Sell |
|
|||||
|
2024
Q4 | $1.27M | Buy |
|
|||||
|
2024
Q3 | $312K | Sell |
|
|||||
|
2024
Q2 | $1.19M | Buy |
|
|||||
|
2024
Q1 | $4.69K | Sell |
|
|||||
|
2023
Q4 | $365K | Buy |
|
|||||
|
2023
Q3 | $68K | Sell |
|
|||||
|
2023
Q2 | $688K | Buy |
|
|||||
|
2023
Q1 | $550K | Sell |
|
|||||
|
2022
Q4 | $643K | Buy |
|
|||||
|
2022
Q3 | $368K | Sell |
|
|||||
|
2022
Q2 | $1.23M | Buy |
|
|||||
|
2022
Q1 | $1.06M | Buy |
|
|||||
|
2021
Q4 | $157K | Sell |
|
|||||
|
2021
Q3 | $562K | Sell |
|
|||||
|
2021
Q2 | $1.43M | Buy |
|
|||||
|
2021
Q1 | $599K | Sell |
|
|||||
|
2020
Q4 | $450K | Buy |
|
|||||
|
2020
Q3 | $46K | Sell |
|
|||||
|
2020
Q2 | $38K | Sell |
|
|||||
|
2020
Q1 | $27K | Sell |
|
|||||
|
2019
Q4 | $134K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $73K | Buy |
|
|||||
|
2019
Q1 | $5K | Sell |
|
|||||
|
2018
Q4 | $132K | Buy |
|
|||||
|
2018
Q3 | $42K | Sell |
|
|||||
|
2018
Q2 | $104K | Buy |
|
|||||
|
2018
Q1 | $2K | Sell |
|
|||||
|
2017
Q4 | $182K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $26K | Sell |
|
|||||
|
2017
Q1 | $88K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $12K | Buy |
|
|||||
|
2016
Q1 | $4K | Buy |
|